首页> 外文期刊>Urology >Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence.
【24h】

Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence.

机译:多中心随机临床试验比较了手术和胶原蛋白注射液治疗女性压力性尿失禁的疗效。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To compare, in a multicenter, randomized clinical trial, collagen injections versus surgery with regard to efficacy, quality of life, satisfaction, and complications. METHODS: Of 133 women with stress urinary incontinence, 66 were randomized to collagen injection and 67 to surgery (6 needle bladder neck suspensions, 19 Burch, and 29 slings). After randomization, 15 women refused their allocated treatment. "Intent-to-treat" and "per protocol" analyses were applied. Women assigned to collagen injection could receive up to three injections before it was considered a failure. A "top-up" injection was allowed within 3 months after cure. Success as the primary outcome at 12 months was defined as a dry 24-hour pad test (2.5 g or less of urine) after having received only the allocated intervention. RESULTS: The per protocol analysis showed that the success rate 12 months after collagen injections (53.1%) was much lower than that after surgery (72.2%). The difference was 19.1% (95% confidence interval -36.2% to -2%). The general and disease-specific quality-of-life scores measured by the Rand Medical Outcomes Study 36-item Health Survey and Incontinence Impact Questionnaire were similar in the two groups (P = 0.306). Women treated by surgery were, on average, more satisfied (79.6%) than those treated by collagen injection (67.2%), but the difference was not significant (P = 0.228). Finally, complications were less frequent and severe with collagen injection: 36 events in 23 subjects for collagen injection versus 84 events in 34 subjects for surgery (P = 0.03). CONCLUSIONS: One year after intervention, the success rate of collagen injection as a treatment for stress urinary incontinence was about 19% lower than that after surgery. This has to be tempered by the similar changes in quality of life and satisfaction in both groups and that the number and severity of complications were much greater after surgery than after collagen injection. The results of this study indicate that collagen injections might be a worthwhile alternative to surgery for the treatment of stress urinary incontinence.
机译:目的:在多中心随机临床试验中,比较胶原蛋白注射剂与手术剂在疗效,生活质量,满意度和并发症方面的关系。方法:在133名压力性尿失禁妇女中,有66名被随机分配进行胶原蛋白注射,而67名则进行了手术(6针膀胱颈悬吊,19 Burch和29悬吊带)。随机分组后,有15名妇女拒绝接受分配的治疗。应用“意图治疗”和“每个方案”分析。被分配胶原蛋白注射液的女性最多可以接受三次注射,然后再被视为失败。治愈后3个月内允许“补足”注射。成功作为12个月时的主要结局定义为仅接受分配的干预措施后,进行24小时干式尿垫试验(尿液2.5 g或更少)。结果:按方案分析表明,注射胶原蛋白后12个月的成功率(53.1%)远低于手术后(72.2%)。差异为19.1%(95%置信区间-36.2%至-2%)。兰德医学成果研究36项健康调查和失禁影响问卷调查所测得的一般和特定疾病的生活质量评分在两组中相似(P = 0.306)。平均而言,接受手术治疗的女性比接受胶原蛋白注射的女性(67.2%)更满意(79.6%),但差异不显着(P = 0.228)。最后,使用胶原蛋白注射的并发症较少且严重:与之相比,胶原蛋白注射的23名受试者发生了36例,而外科手术的34名受试者则发生了84例(P = 0.03)。结论:干预后一年,注射胶原蛋白治疗压力性尿失禁的成功率比手术后低约19%。两组患者的生活质量和满意度都有类似的变化,这必须加以缓解,并且手术后并发症的数量和严重程度要比胶原蛋白注射后大得多。这项研究的结果表明,胶原蛋白注射剂可能是替代手术治疗压力性尿失禁的一种有价值的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号